GLP-1 receptor agonists show promise beyond obesity but require careful use due to sarcopenia risk and complex effects on mental health.

Investigators sought to determine when malnutrition appears in patients with GI cancer and how nutritional status affects quality of life and fatigue during treatment.

Liver cirrhosis, the common endpoint of chronic liver disease, is characterized by diffuse fibrosis, pseudolobule formation, and vascular distortion ...

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED ...

Fatigue, low energy – or something more serious: What sudden weight loss could mean, even from GLP-1s - The side effects of ...

Company to host a webcast today at 8:30 am Eastern Time NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage ...

Thank you, Clint, and good morning, everyone. As we enter 2026, we continue to progress our innovative clinical pipeline with ...

Sarcopenia, the progressive loss of skeletal muscle mass, strength, and function with aging, is a key driver of frailty, ...

Weight loss is a well-recognized but poorly understood non-motor feature of Parkinson's disease (PD). Many patients progressively lose weight as the disease advances, often alongside worsening motor ...

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2026 Earnings Call Transcript February 9, 2026 Anavex Life Sciences Corp. beats ...

A study of mice fed a high-fat/high-fructose diet (designed to induce obesity) found that 12 weeks of treatment with low-dose psilocybin reduced weight gain, symptoms of fatty liver, hyperglycemia, ...

GI side effects. These are common with these medications and can include nausea, diarrhea, abdominal pain, and vomiting. “Symptoms are often tolerable in younger patients; they can precipitate serious ...